These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15372479)

  • 1. What is 'insignificant' prostate carcinoma?
    Klein EA
    Cancer; 2004 Nov; 101(9):1923-5. PubMed ID: 15372479
    [No Abstract]   [Full Text] [Related]  

  • 2. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.
    Johnstone PA; Rossi PJ; Jani AB; Master V
    Prostate Cancer Prostatic Dis; 2007; 10(3):237-41. PubMed ID: 17387320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate tumors].
    Devonec M
    Rev Prat; 2002 Jan; 52(2):207-12. PubMed ID: 11915568
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Aus G
    Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for prostate carcinoma: prostate-specific antigen--friend or foe?
    D'Amico AV
    Cancer; 2005 Mar; 103(5):881-3. PubMed ID: 15637686
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of morphometric measurements of prostate carcinoma volume.
    Renshaw A
    Cancer; 2002 Apr; 94(8):2309-10. PubMed ID: 12001133
    [No Abstract]   [Full Text] [Related]  

  • 9. PSA scores: should we use a lower threshold?
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostatic punch biopsy].
    Braun M; Engelmann U
    Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer in men with serum PSA of <4 ng/ml: under-diagnosed or over-treated?
    Yossepowitch O
    Eur Urol; 2008 Apr; 53(4):686-8. PubMed ID: 17997025
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting the risk of prostate cancer on biopsy.
    Ebell MH
    Am Fam Physician; 2005 Sep; 72(6):1091-2. PubMed ID: 16190507
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment.
    Carroll PR; Whitson JM
    Urology; 2011 Apr; 77(4):984-5. PubMed ID: 21477729
    [No Abstract]   [Full Text] [Related]  

  • 14. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
    Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
    Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PSA level--is 4.0 ng/ml as upper limit too high].
    Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening: is it possible to explain diametrically opposed views?
    Richardson A
    N Z Med J; 2005 Feb; 118(1209):U1289. PubMed ID: 15711622
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the pathologist in diagnosing prostate cancer and guiding therapy.
    Weinstein MH
    N C Med J; 2006; 67(2):140-5. PubMed ID: 16752719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?
    Gosselaar C; Roobol MJ; Schröder FH
    BJU Int; 2005 Feb; 95(2):231-7. PubMed ID: 15667646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.